FDA Clears Blood Test for Alzheimer's Amyloid Pathology Detection
The U.S. Food and Drug Administration has cleared a new blood test designed to help identify amyloid pathology associated with Alzheimer's disease in adults with cognitive symptoms.
Understand the story, not the spin.
Recent Verilumia coverage about Labcorp Holdings Inc. (LH), including reporting-tone insights and market listing information.
The U.S. Food and Drug Administration has cleared a new blood test designed to help identify amyloid pathology associated with Alzheimer's disease in adults with cognitive symptoms.